Metabolic phenotyping of human atherosclerotic plaques: Metabolic alterations and their biological relevance in plaque-containing aorta.
暂无分享,去创建一个
Eui-Young Choi | Se Hoon Kim | Do Hyun Ryu | G. Hwang | Sunhee Jung | Sunhee Jung | Sang‐Hak Lee | Geum-Sook Hwang | Seung Hyun Lee | Sak Lee | Hyun-Chel Joo | Gijong Yi | Soo-jin Ann | Suk-Won Song | Gijong Yi | Sak Lee | Soo-Jin Ann | Eun Jeong Cheon | Hyun-Chel Joo | Sang-Hak Lee | D. Ryu | E. Cheon | E. Choi | S. H. Kim | Suk-Won Song | S. Lee | Suk-Won Song | Suk-Won Song
[1] Jian-Ping Zuo,et al. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. , 2009, Antiviral research.
[2] M. Davies,et al. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. , 2006, Free radical biology & medicine.
[3] R. Draijer,et al. Impact of short-term intake of red wine and grape polyphenol extract on the human metabolome. , 2012, Journal of agricultural and food chemistry.
[4] C. di Ilio,et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. , 1998, Circulation.
[5] Robert S Plumb,et al. Global metabolic profiling of animal and human tissues via UPLC-MS , 2012, Nature Protocols.
[6] H. Kruth,et al. Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[7] J. Sullivan. Iron in arterial plaque: modifiable risk factor for atherosclerosis. , 2009, Biochimica et biophysica acta.
[8] D. Harrison,et al. Role of oxidative stress in atherosclerosis. , 2003, The American journal of cardiology.
[9] S. Chatterjee. Sphingolipids in atherosclerosis and vascular biology. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[10] K. Chida,et al. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.
[11] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[12] A. Davies,et al. Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis. , 2015, Journal of proteome research.
[13] A. Orekhov,et al. Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue. , 1989, European journal of biochemistry.
[14] D. Raftery,et al. Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.
[15] T. Lehtimäki,et al. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study , 2010, Annals of medicine.
[16] A. Davies,et al. Metabolic Phenotypes of Carotid Atherosclerotic Plaques Relate to Stroke Risk: An Exploratory Study. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[17] F Santeusanio,et al. Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study , 2000, Hypertension.
[18] J. Michel,et al. Metabolites secreted by human atherothrombotic aneurysms revealed through a metabolomic approach. , 2011, Journal of Proteome Research.
[19] D. Fuchs,et al. Immune activation and degradation of tryptophan in coronary heart disease , 2003, European journal of clinical investigation.
[20] E. Bertini,et al. Analysis of glutathione: implication in redox and detoxification. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[21] S. Tyagi,et al. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle , 2004, Nutrition & metabolism.
[22] M. Runge,et al. Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[23] G. Hwang,et al. Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet , 2015, Scientific Reports.
[24] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[25] J. Borén,et al. Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation. , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[26] D. Townsend,et al. The importance of glutathione in human disease. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[27] J. Mehta,et al. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. , 2006, The international journal of biochemistry & cell biology.
[28] F. Priego-Capote,et al. Analysis of serum phospholipid profiles by liquid chromatography-tandem mass spectrometry in high resolution mode for evaluation of atherosclerotic patients. , 2014, Journal of chromatography. A.
[29] A. Davies,et al. Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease , 2015, Analytical chemistry.
[30] Ning Zhang,et al. Plasma metabolomics reveals biomarkers of the atherosclerosis. , 2010, Journal of separation science.
[31] G. Hutchins,et al. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. , 1997, Glycobiology.
[32] R. Feinman,et al. What is Nutrition & Metabolism? , 2004, Nutrition & Metabolism.
[33] M. Davies,et al. Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[34] J. Egido,et al. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. , 2009, Journal of proteome research.
[35] B. Afşar,et al. The role of uric acid in the pathogenesis of human cardiovascular disease , 2013, Heart.
[36] A. Davies,et al. Systems Biology of Human Atherosclerosis , 2014, Vascular and endovascular surgery.
[37] D. Ramji,et al. Interferon-g and atherosclerosis : Pro-or anti-atherogenic ? , 2005 .
[38] T. Lehtimäki,et al. Indoleamine 2,3‐dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study , 2007, Clinical and experimental immunology.
[39] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[40] Yong Sup Lee,et al. Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus. , 2006, Journal of natural products.
[41] G. Hwang,et al. LC/MS-based polar metabolite profiling reveals gender differences in serum from patients with myocardial infarction. , 2015, Journal of pharmaceutical and biomedical analysis.